Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 14
1983 5
1984 17
1985 12
1986 10
1987 11
1988 17
1989 16
1990 22
1991 27
1992 35
1993 41
1994 52
1995 63
1996 56
1997 67
1998 118
1999 121
2000 117
2001 129
2002 134
2003 122
2004 112
2005 130
2006 131
2007 121
2008 117
2009 111
2010 107
2011 110
2012 119
2013 90
2014 112
2015 85
2016 81
2017 72
2018 83
2019 85
2020 117
2021 104
2022 107
2023 88
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

3,097 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R, Harrison T, Peterson S, Gustafson P, Hamblin A, Bengtsson T, Fagerås M. Beasley R, et al. JAMA Netw Open. 2022 Mar 1;5(3):e220615. doi: 10.1001/jamanetworkopen.2022.0615. JAMA Netw Open. 2022. PMID: 35230437 Free PMC article.
Included patients were adults and adolescents with asthma and baseline Asthma Control Questionnaire 5-item version scores of 1.5 or higher. ...For patients with uncontrolled asthma at step 3 and step 4 (n = 2913), switching to SMART was associated with a prol …
Included patients were adults and adolescents with asthma and baseline Asthma Control Questionnaire 5-item version scores of 1 …
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Yi F, Zhan C, Liu B, Li H, Zhou J, Tang J, Peng W, Luo W, Chen Q, Lai K. Yi F, et al. Respir Res. 2022 Oct 10;23(1):279. doi: 10.1186/s12931-022-02114-6. Respir Res. 2022. PMID: 36217131 Free PMC article. Clinical Trial.
BACKGROUND: Whether cysteinyl-leukotriene receptor antagonists (LTRAs) have a similar antitussive effect to inhaled corticosteroids and long-acting beta2-agonist (ICS/LABA), and that LTRA plus ICS/LABA is superior to LTRAs alone or ICS/LABA alone in treating cough variant asth …
BACKGROUND: Whether cysteinyl-leukotriene receptor antagonists (LTRAs) have a similar antitussive effect to inhaled corticosteroids and long …
A Practical Guide to Implementing SMART in Asthma Management.
Reddel HK, Bateman ED, Schatz M, Krishnan JA, Cloutier MM. Reddel HK, et al. J Allergy Clin Immunol Pract. 2022 Jan;10(1S):S31-S38. doi: 10.1016/j.jaip.2021.10.011. Epub 2021 Oct 16. J Allergy Clin Immunol Pract. 2022. PMID: 34666208 Review.
The use of a single inhaler containing the combination of an inhaled corticosteroid (ICS) and formoterol, a specific long-acting bronchodilator, for both maintenance and quick relief therapy (single maintenance and reliever therapy [SMART or MART]) is recommended by both the Glob …
The use of a single inhaler containing the combination of an inhaled corticosteroid (ICS) and formoterol, a specific long-acting bronchodila …
What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?
Jenkins CR, Bateman ED, Sears MR, O'Byrne PM. Jenkins CR, et al. Respirology. 2020 Aug;25(8):804-815. doi: 10.1111/resp.13804. Epub 2020 Mar 31. Respirology. 2020. PMID: 32237004 Free article. Review.
The data confirm that patients with asthma treated with budesonide/formoterol MART achieved the same or better asthma symptom control compared with ICS/LABA plus SABA regimens at similar or higher ICS doses, with consistently lower rates of exacerbations and …
The data confirm that patients with asthma treated with budesonide/formoterol MART achieved the same or better asthma s …
Budesonide/formoterol maintenance and reliever therapy in childhood asthma: Real-world effectiveness and economic assessment.
Yu Y, Cao W, Xiao Y, Li A, Huang H, Liu K, Hu L, Hou X, Xiang L, Wang X. Yu Y, et al. Pediatr Pulmonol. 2023 Dec;58(12):3406-3415. doi: 10.1002/ppul.26647. Epub 2023 Oct 11. Pediatr Pulmonol. 2023. PMID: 37818789
A total of 103 patients under 18 years old in the SMART group and 63 patients in the control group were included from January 1, 2020 to December 31, 2021. The effectiveness was assessed using asthma attacks and lung function at baseline, 6 months and 12 months follow-up. …
A total of 103 patients under 18 years old in the SMART group and 63 patients in the control group were included from January 1, 2020 to Dec …
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management.
Daley-Yates P, Singh D, Igea JM, Macchia L, Verma M, Berend N, Plank M. Daley-Yates P, et al. Adv Ther. 2023 Sep;40(9):4042-4059. doi: 10.1007/s12325-023-02585-z. Epub 2023 Jul 12. Adv Ther. 2023. PMID: 37438554 Free PMC article. Review.
This article reviews efficacy versus systemic activity profiles for various adherence patterns and dosing regimens of fluticasone furoate (FF)-containing and budesonide (BUD)-containing asthma therapies in clinical trials and real-world studies. ...CONCLUSION: In th …
This article reviews efficacy versus systemic activity profiles for various adherence patterns and dosing regimens of fluticasone furoate (F …
The role of budesonide/formoterol for maintenance and relief in the management of asthma.
Kaplan A, Ryan D. Kaplan A, et al. Pulm Pharmacol Ther. 2010 Apr;23(2):88-96. doi: 10.1016/j.pupt.2009.10.011. Epub 2009 Oct 28. Pulm Pharmacol Ther. 2010. PMID: 19878732 Review.
The aim of asthma management is to gain and maintain asthma control and reduce the risk of future exacerbations. ...A web-based literature review was undertaken with a focus on studies and reviews discussing asthma control and management with traditional ther …
The aim of asthma management is to gain and maintain asthma control and reduce the risk of future exacerbations. ...A web-base …
Nebulized Inhaled Corticosteroids in Asthma Treatment in Children 5 Years or Younger: A Systematic Review and Global Expert Analysis.
Murphy KR, Hong JG, Wandalsen G, Larenas-Linnemann D, El Beleidy A, Zaytseva OV, Pedersen SE. Murphy KR, et al. J Allergy Clin Immunol Pract. 2020 Jun;8(6):1815-1827. doi: 10.1016/j.jaip.2020.01.042. Epub 2020 Jan 30. J Allergy Clin Immunol Pract. 2020. PMID: 32006721 Free article. Review.
This systematic review aimed to clarify the role of NebCSs in children 5 years or younger for the management of acute asthma exacerbations, asthma maintenance therapy, and the treatment of VIW. ...Results showed NebCSs to be at least as efficacious as oral corticost …
This systematic review aimed to clarify the role of NebCSs in children 5 years or younger for the management of acute asthma exacerba …
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma.
Pelaia G, Vatrella A, Busceti MT, Fabiano F, Terracciano R, Matera MG, Maselli R. Pelaia G, et al. Pulm Pharmacol Ther. 2016 Oct;40:15-21. doi: 10.1016/j.pupt.2016.07.001. Epub 2016 Jul 2. Pulm Pharmacol Ther. 2016. PMID: 27381656 Review.
Inhaled glucocorticoids are the mainstay of asthma treatment. Indeed, such therapeutic agents effectively interfere with many pathogenic circuits underpinning asthma. ...Therefore, a large body of evidence clearly shows that budesonide, either alone or in com …
Inhaled glucocorticoids are the mainstay of asthma treatment. Indeed, such therapeutic agents effectively interfere with many pathoge …
Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma.
Humbert M, Andersson TL, Buhl R. Humbert M, et al. Allergy. 2008 Dec;63(12):1567-80. doi: 10.1111/j.1398-9995.2008.01863.x. Allergy. 2008. PMID: 19032229 Review.
The Global Initiative for Asthma (GINA) guidelines aim at improving asthma control and preventing future risk. ...These benefits are achieved at a lower overall steroid load, and budesonide/formoterol maintenance and reliever therapy is well tolerated in pati …
The Global Initiative for Asthma (GINA) guidelines aim at improving asthma control and preventing future risk. ...These benefi …
3,097 results